Clinical trials: Genital Neoplasms
Prostate Cancer
STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies
Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies…
- Trial name
- NCT02788825
- Testing
- Targeted biopsies using Magnetic Resonance Imaging guiding
- Where
- 2 sites in Norway, Sweden
- Volunteers
- 687 people
- Sponsor
- Karolinska Institutet
Prostate Cancer
Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer
As choline transport and phosphorylation are upregulated in most cancers, including prostate cancer, positron emission tomography (PET) with choline tracers has found widespread use to detect recurrent disease.
- Trial name
- TEPGALCHOL (NCT03623425)
- Testing
- 68Ga-PSMA-11 PET, 18F-FCH PET
- Where
- France
- Volunteers
- 46 people
- Sponsor
- Central Hospital, Nancy, France
Polycystic Ovary Syndrome, IVF
Follicular Fluid Raman Shifts and IVF Outcomes
This study intends to collect about 150 cases of follicular fluid samples from PCOS and non-PCOS infertility patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles (in clinical…
- Trial name
- NCT04838535
- Testing
- Raman spectrum
- Where
- China
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
Prostatic Neoplasms
A Registry of Participants With Prostate Cancer in Asia
The purpose of this study is to document prostate cancer (PC) management including diagnosis, prognosis, treatment, and care in real-world practice.
- Trial name
- NCT02546908
- Testing
- No Intervention
- Where
- 31 sites in China, India and 6 more
- Volunteers
- 3,644 people
- Sponsor
- Janssen Research & Development, LLC
Cervical Cancer Stage IV, Vulvar Cancer, Stage IV
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Current therapies for Stage IV Cancer of the Cervix and/or Vulva provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV…
- Trial name
- NCT00003525
- Testing
- Antineoplaston therapy (Atengenal + Astugenal)
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Burzynski Research Institute
Cervical Cancer
Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer
Cervical cancer is the fourth most common cancer type among women worldwide and ranks ninth in Turkey, making it the second most common gynecological cancer.
- Trial name
- NCT06705309
- Testing
- Web-Based Education
- Where
- Turkey (Türkiye)
- Volunteers
- 128 people, healthy volunteers welcome
- Sponsor
- Istanbul University - Cerrahpasa
Polycystic Ovary Syndrome, Ovulation
The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome
Title: The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2019: Randomized Double-Blind Placebo-controlled trial Phase: III Population: 118 women with polycystic ovary…
- Trial name
- PCOS (NCT03778099)
- Testing
- Cinnamon Cap 500 MG
- Where
- Saudi Arabia
- Volunteers
- 33 people
- Sponsor
- King Abdulaziz University
Tissue Repair, Soft Tissue Reconstruction
Urinary Bladder Matrix (UBM) Registry
The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products.
- Conditions
- Tissue Repair, Soft Tissue Reconstruction, Wound Management, Pressure Ulcer (PU)
- Trial name
- NCT07805798
- Testing
- Urinary Bladder Matrix (UBM) Products
- Volunteers
- 300 people
- Sponsor
- Integra LifeSciences Corporation
Cancer Colorectal, Cancer Cervix
Building Connections
Building Connections seeks to address health and healthcare inequities in socially vulnerable communities. The project will be conducted in collaboration with clinical practices across Massachusetts, serving a diverse population…
- Conditions
- Cancer Colorectal, Cancer Cervix, Depression, Anxiety, Obesity
- Trial name
- NCT07091032
- Testing
- Treatment as Usual, Building Connections Intervention
- Where
- United States
- Volunteers
- 3,600 people
- Sponsor
- Massachusetts General Hospital
Head and Neck Cancer, Prostate Cancer
Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers
Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt.
- Trial name
- NCT01535898
- Testing
- MRI scanner with sequence
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Memorial Sloan Kettering Cancer Center
Cervical Cancer, Gynecologic Malignancies
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Recombinant oncolytic adenovirus injection (KD01)is an oncolytic vius product. Its main component is a conditionally replicativerecombinant human type 5 adenovirus, where part of the E3 region has been replaced with the gene…
- Conditions
- Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer
- Trial name
- NCT06552598
- Testing
- KD01(the recombinant oncolytic adenovirus)
- Where
- China
- Volunteers
- 97 people
- Sponsor
- Tongji Hospital
Endometrial Cancer
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial cancer.
- Trial name
- NCT03526432
- Testing
- Bevacizumab, Atezolizumab
- Where
- 3 sites in United States
- Volunteers
- 110 people
- Sponsor
- University of Oklahoma
Prostatic Neoplasm
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
The purpose of this study is to evaluate the efficacy and safety of AAA617 alone (Lutetium [177Lu] vipivotide tetraxetan) and in combination with an Androgen Receptor Pathway Inhibitors (ARPI) in participants with PSMA-positive…
- Trial name
- PSMACare (NCT05849298)
- Testing
- AAA617, AAA517, Piflufolastat F 18
- Where
- 31 sites in United States, Brazil and 9 more
- Volunteers
- 49 people
- Sponsor
- Novartis Pharmaceuticals
Prostatic Neoplasms
Docetaxel in the Treatment of Hormone Refractory Prostate Cancer
Evaluation of safety and efficacy of docetaxel in the treatment of advanced hormone refractory prostate cancer under the conditions of daily practise.
- Trial name
- NCT00280098
- Testing
- docetaxel
- Where
- Czechia
- Volunteers
- 30 people
- Sponsor
- Sanofi
Extragonadal Germ Cell Tumor, Teratoma
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
RATIONALE: Drugs used in chemotherapy, such as bleomycin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
- Conditions
- Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor
- Trial name
- NCT00453232
- Testing
- bleomycin sulfate, pegfilgrastim, cisplatin
- Where
- 7 sites in United Kingdom
- Volunteers
- 20 people
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
Localized Prostate Cancer
WATER IV Prostate Cancer
This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for…
- Trial name
- WATER IV PCa (NCT06651632)
- Testing
- Aquablation Therapy, Radical Prostatectomy
- Where
- 37 sites in United States, Canada and 5 more
- Volunteers
- 280 people
- Sponsor
- PROCEPT BioRobotics
Cancer
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
RATIONALE: When irradiated lymphocytes from a donor are infused into the patient they may help the patient's immune system kill cancer cells.
- Trial name
- NCT00161187
- Testing
- therapeutic allogeneic lymphocytes
- Where
- United States
- Volunteers
- 37 people
- Sponsor
- University of Medicine and Dentistry of New Jersey
Prostate, Prostate Cancer
Focal Therapy in Localized Prostate Cancer: a Prospective Registry
The principal aim of the registry is to collect data on focal therapy (FT) for the treatment of intermediate-risk prostate cancer across Europe.
- Trial name
- JR (NCT06772116)
- Testing
- Focal Therapy
- Volunteers
- 1,000 people
- Sponsor
- Institut Mutualiste Montsouris
Prostate Cancer
Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate
The investigators hypothesize software-based fusion/navigation will be accurate to within 3 mm of the reference standard of EM fusion.
- Trial name
- NCT02882958
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Massachusetts General Hospital
Prostatic Neoplasms, Metastasis
SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy
The goal of this single blind placebo-controlled intervention study is to examine the impact of a supervised training program on disease-related quality of life and physical fitness in patient with advanced prostate cancer…
- Trial name
- Superman (NCT06282185)
- Testing
- Physiotherapy
- Where
- Netherlands
- Sponsor
- Canisius-Wilhelmina Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.